logo
Share SHARE
FONT-SIZE Plus   Neg

Endo Buys US Patent For Oxymorphone From Johnson Matthey - Quick Facts

Endo Pharmaceuticals Holdings (ENDP) said it has acquired U.S. patent for oxymorphone hydrochloride, the key API in all formulations of OPANA, from Johnson Matthey plc (JMAT.L).

By acquiring Johnson Matthey's patent to the oxymorphone ingredient, which will be listed in the U.S. Food and Drug Administration's Orange Book, Endo will enjoy additional patent protection for its OPANA franchise, now through 2029.

"This patent not only covers our newly designed to be crush resistant OPANA® ER, it covers all products that include oxymorphone that are manufactured in accordance with current FDA specifications," said Julie McHugh, chief operating officer of Endo.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Eric Daniels, the former chief executive of Lloyds Banking Group, is suing the bank for hundreds of thousands of pounds in disputed bonuses, The Times reported. He was at the top job when the lender was bailed out with 20 billion pounds of taxpayer money during the 2008 financial crisis. Lowe's Companies, Inc. (LOW) reported second-quarter net earnings of $1.4 billion or $1.68 per share compared to $1.2 billion or $1.31 per share, a year ago. The second quarter results included a $96 million gain from the sale of the company's interest in its Australian joint venture. Excluding the gain,... Wal-Mart has applied for a U.S. patent for a blimp-style floating warehouse that could make deliveries through drones, Bloomberg reported. The world's largest retailer expects the proposed floating warehouse could help it lower the costs of fulfilling online orders, especially the expensive last-mile deliveries..
comments powered by Disqus
Follow RTT